2型糖尿病与糖尿病共病抑郁患者的临床指标差异及抑郁标志物研究

MRP

Medical Research and Practice

2993-96902993-9704

Art and Technology

10.61369/MRP.2026060011

Article

2型糖尿病与糖尿病共病抑郁患者的临床指标差异及抑郁标志物研究https://artdesignp.com/journal/MRP/4/6/10.61369/MRP.2026060011袁改玲,李蓉,李文军,罗肖兵,刘星

2026

2026-06-20

目的：比较单纯2型糖尿病（type 2 diabetes mellitus ，T2DM）患者与糖尿病共病抑郁（type 2 diabetes comorbid depression, T2DD）患者在人口学特征、代谢指标、炎症指标及内分泌指标等方面的差异，筛选潜在抑郁标志物。方法：选取2024年1月至12月新疆生产建设兵团第五师医院内分泌科收治的132例2型糖尿病患者。所有参与者均签署知情同意书，并接受详细的问卷调查和体检。研究数据包括社会人口学信息、临床信息、实验室检查和心理评估。心理评估采用流调中心用抑郁量表（CES-D）和Beck抑郁量表（BDI），CES-D≥20且BDI≥5定义为抑郁状态。采集外周静脉血，检测血小板计数（PLT）、中性粒细胞计数(NE)、淋巴细胞计数(LY)、平均血小板体积（MPV）、血小板压积（PCT）、血小板分布宽度（PDW）、糖化血红蛋白（HbA1c）、纤维蛋白原（FIB）、血脂谱（TC、TG、HDL-C、LDL-C）、胰岛素（INS）和C肽（C-P）、促甲状腺激素（TSH）、25-羟基维生素D（25-OH-VD）。同时记录人口学数据：性别、年龄、身高、体重。采用SPSS 26.0进行统计学分析。结果：两组在民族、性别、年龄构成、BMI、PLT、MPV、PCT、PDW、HbA1c、TC、TG、HDL-C、LDL-C、TSH水平上差异均无统计学意义（P均>0.05），SII、FIB、25-OH-VD、INS、C-P有统计学意义，但进行多因素logistic回归分析后，显示25-OH-VD是T2DD最强的独立危险因素（P=0.006）、OR=0.901（95%CI: 0.838-0.970），SII（系统性免疫炎症指数）和C-P水平也显示出一定的预测价值，值得在临床实践中关注。结论:联合使用C-P、SII和25-OH-VD可显著提高T2DD的诊断准确性，在实际临床中，可先使用SII进行初步筛查，再结合C-P和25-OH-VD进行确认诊断。2型糖尿病,抑郁,糖化血红蛋白,系统免疫炎症指数,25-羟基维生素D

[1]MARKLE-REID M, PLOEG J, FRASER K D, et al. Community Program Improves Quality of Life and Self-Management in Older Adults with Diabetes Mellitus and Comorbidity[J]. J Am Geriatr Soc, 2018, 66(2): 263–73.[2]ALBERTI K G, ZIMMET P Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation [J]. Diabet Med, 1998, 15(7): 539–53.[3]MAJUMDAR S, SINHA B, DASTIDAR B G, et al. Assessing prevalence and predictors of depression in Type 2 Diabetes Mellitus (DM) patients - The DEPDIAB study [J]. Diabetes Res Clin Pract, 2021, 178: 108980.[4]MOUSSAVI S, CHATTERJI S, VERDES E, et al. Depression, chronic diseases, and decrements in health: results from the World Health Surveys [J]. Lancet, 2007, 370(9590): 851–8.[5]COONEY G M, DWAN K, GREIG C A, et al. Exercise for depression [J]. Cochrane Database Syst Rev, 2013, 2013(9): Cd004366.[6]HAMMAR A, ARDAL G. Cognitive functioning in major depression--a summary [J]. Front Hum Neurosci, 2009, 3: 26.[7]JAYAKODY K, GUNADASA S, HOSKER C. Exercise for anxiety disorders: systematic review [J]. Br J Sports Med, 2014, 48(3): 187–96.[8]SCHRAM M T, BAAN C A, POUWER F. Depression and quality of life in patients with diabetes: a systematic review from the European depression in diabetes (EDID) research consortium [J]. Curr Diabetes Rev, 2009, 5(2): 112–9.[9]LIN E H, HECKBERT S R, RUTTER C M, et al. Depression and increased mortality in diabetes: unexpected causes of death [J]. Ann Fam Med, 2009, 7(5): 414–21.[10]ANGEVAREN M, AUFDEMKAMPE G, VERHAAR H J, et al. Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairment [J]. Cochrane Database Syst Rev, 2008, (3): Cd005381.[11]LUSTMAN P J, CLOUSE R E. Depression in diabetic patients: the relationship between mood and glycemic control [J]. J Diabetes Complications, 2005, 19(2): 113–22.[12]IZZI B, TIROZZI A, CERLETTI C, et al. Beyond Haemostasis and Thrombosis: Platelets in Depression and Its Co-Morbidities [J]. Int J Mol Sci, 2020, 21(22).[13]孙莉, 阚李梅, 张莹, 等. 血小板活化及血小板聚集率对2型糖尿病共病抑郁的诊断价值 [J]. 国际检验医学杂志, 2023, 44(12): 1416–20.[14]CENTENO L O L, LONGONI A, TRETTIM J P, et al. Vitamin D Deficiency During Pregnancy Is Associated with Postpartum Depression: A Cohort Study in Southern Brazil [J]. Nutrients, 2025, 17(23).[15]VAN REEDT DORTLAND A K, GILTAY E J, VAN VEEN T, et al. Associations between serum lipids and major depressive disorder: results from the Netherlands Study of Depression and Anxiety (NESDA) [J]. J Clin Psychiatry, 2010, 71(6): 729–36.[16]OGUNTIBEJU O O. Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links [J]. Int J Physiol Pathophysiol Pharmacol, 2019, 11(3): 45–63.[17]STRAWBRIDGE R, ARNONE D, DANESE A, et al. Inflammation and clinical response to treatment in depression: A meta-analysis [J]. Eur Neuropsychopharmacol, 2015, 25(10): 1532–43.[18]HENEIN M Y, VANCHERI S, LONGO G, et al. The Role of Inflammation in Cardiovascular Disease [J]. Int J Mol Sci, 2022, 23(21).[19]CHEN G, XU R, WANG Y, et al. Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathy [J]. Am J Physiol Endocrinol Metab, 2012, 303(5): E563–75.[20]FINGER B C, DINAN T G, CRYAN J F. High-fat diet selectively protects against the effects of chronic social stress in the mouse [J]. Neuroscience, 2011, 192: 351–60.[21]ALI S Y, SADIK M I, SEID A M, et al. Association of systemic immune inflammation index with depression among adult type 2 diabetic patients in a tertiary hospital, Ethiopia, 2022 [J]. Front Endocrinol (Lausanne), 2025, 16: 1454793.[22]CHRISTAKOS S, DHAWAN P, VERSTUYF A, et al. Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects [J]. Physiol Rev, 2016, 96(1): 365–408.[23]PUTRANTO R, SETIATI S, NASRUN M W, et al. Effects of cholecalciferol supplementation on depressive symptoms, C-peptide, serotonin, and neurotrophin-3 in type 2 diabetes mellitus: A double-blind, randomized, placebo-controlled trial [J]. Narra J, 2024, 4(3): e1342.